I know we are a flu and hep c stock
but our ebola run may not be out of reach ...
search this article (its linked on twitter too):
August 20, 2014
Successful Marburg Virus Treatment Offers Hope for Ebola Patients
A new approach, similar to one previously tested on Ebola, saved monkeys up to three days after infection with Marburg virus"
May God, and Bud, bless each and every one of those monkeys (NOT the stock monkeys though)
we need her on this mullet mountain
no I think its VERY serious
that 35 share trade, followed by a 10 share trade, in combo, scared the poopy outa me
my guess is that dmd was declared unconstitutional
8 of 12 was well good enough
the fda knows that at least two of the boys have general anesthesia issues
so the real world max was 10
cep says they have 8
what is your biggest bestest impending thing for the Srpt dmd front?
the nda filing by year-end?
star's impending arrest for stalking CG's office?
mine is the FOURTH BIOPSY
the CEO has twice publicly confirmed it is finally happening later this year
think about it
what is bigger for every long and short investment thesis ...
the nda app delivery to fda by year end (remember, FDA acceptance or denial of same will not likely be known until jan-feb 2015)
confirmation that increased levels of dystrophin in fact exist in the srpt trial boys, or not
if you think its door #1, then you are a galactic imbecile
the 4th biop results will establish the clear path, up or down
if that biop is done with fda guidance (which it will be), and shows good dystrophin, even eric hoffman will have to get on board!
IMO, the entire market will assume that fda AA is a done deal off dystrophin as a surrogate marker!
and if the dystrophin results suck, well then, we also have clarity, on the way down the dumper
the ceo suggested we might not have the results by year-end that the 4th biop results would have to be an addition to the by then filed nda
assuming the nda is filed right at year end, I say that is rubblish as the biop results should be known by 2014 year end
but if the nda goes in by november, then it is likely an addtional item after filing
either way, I say the 4th biop will clarify all confusion, up or down
so srpt has disclosed that it has ebola drug ready (in a week's notice) to treat around 24 patients, and if asked, could have drug for around 100 more within 2 months
the US government owns the drug that is available for 24 patients (not sure about who wouold own the new drug to be made)
the ebola epidemic is still getting worse, particularly in Liberia (84 new deaths in 5 days)
SO WHY HAS THE US GOV NOT TAKEN THE SRPT EBOLA DRUG FOR THE 24 PATIENTS AND GIVEN IT AWAY ALREADY?! ...
seems like a head scratcher, but maybe NOT
here is my guess
the fed still thinks that ebola could possbly find its way to US, by accident ... or on purpose (and the attack on the ebola treatment facility the other day surely did not relieve this fear!)
perhaps the fed is sitting on the srpt ebola drug supply as a "just in case measure"
it cannot be because the fed forgot about the srpt drug supply, or does not care about it
THERE HAS TO BE A REASON
the fed is saving it
I am going flat out quadruple down on you
I say the stock is 400 times the Cowen target!
and star says 800 times, continent on the srpt CEO having his finger nails ripped off with a rusty pliers
this is what I learned, for sure
star appears quite #$%$ off at the CEO!
I am all caught up now
your failure to see the inner beauty in nekkid's posts is quite disappointing
pleez see dr F for an appointment to get your attitude adjusted
if you are saying that the fda will approve the srpt ebola drug for use by others, I agree wtih you
its the details of that use that could be complicated though (who gets it, and at what stage of the dread are they when they get it ... when you are a public company you have to worry about these things, because perception impacts your stock)
for example, what if the srpt ebola drug was given mostly, or all, to people who were too far gone to really help, and the perception was that the drug " did not work"?
none of this is SIMPle
I have a question beamcounter
are you aware of the rumor that our friend nekkid put a mullet price target of 4.75 on zixi?
you might wanna get on the nekkid band wagon
I do not know why you are directing this to me
I have never, do not now, and never will, have you on Ignore
cuz I find your posts to universally be a very refreshing, complete and total detachment from reality
everything has its place
"Typically, the Food and Drug Administration doesn't regulate shipments of unapproved drugs for emergency use in individual patients outside the U.S."
I will answer
i bought all my stock at $96
but then I lost money on monthly options for 96 straight months
my all in COB is $107.98
i expect to double my money